Andrew Bellinger

Andrew Bellinger is currently serving as Chief Scientific Officer at Verve Therapeutics and as Co-Founder at Corner Therapeutics. With a background in medicine, biochemistry, and molecular biology, Andrew has held various leadership roles in pharmaceutical development, clinical development, and scientific communication. Andrew has also co-founded and led R&D at Lyndra. Andrew's experience includes positions at prestigious institutions such as MIT, Harvard Medical School, and UCSF Medical Center.